Structure Therapeutics

GPCRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.777 B

$53.14 +0.99%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$141.2M

Loss-making

Shares outstanding

213,929,572

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#69Telix PharmaceuticalsTLX$3.90B
#70Legend BiotechLEGN$3.85B
#71Structure TherapeuticsGPCR$3.78B
#72Aktis OncologyAKTS$3.73B
#73Arcus BiosciencesRCUS$3.64B

Where these numbers come from

Share counts and financials for Structure Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.